Human herpesvirus 6 infections after bone marrow transplantation: Clinical and virologic manifestations

Journal of Infectious Diseases

Volumn 179, Issue 2, 1999, Pages 311-318

  Cone, Richard W ^a,b   Huang, Meei Li W ^a   Corey, Lawrence ^a,c   Zeh, Judith ^a   Ashley, Rhoda ^a   Bowden, Raleigh ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CISPLATIN; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE;

ANTIBODY TITER; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENOTYPE; GRAFT VERSUS HOST REACTION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SEROCONVERSION; VIREMIA; VIRUS ISOLATION; VIRUS REACTIVATION; VIRUS REPLICATION;

ADULT; BONE MARROW TRANSPLANTATION; COHORT STUDIES; CYTOMEGALOVIRUS; DNA, VIRAL; EXANTHEMA; FEMALE; FEVER; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 0032978355     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314581     Document Type: Article

References (35)

1. Levy JA, Ferro F, Greenspan D, Lennette E. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990;335:1047-50.
2. Cone RW, Huang ML, Ashley R, Corey L. HHV-6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol 1993;31:1262-7.
3. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988;1:1065-7.
4. Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N Engl J Med 1994;331:432-8.
5. Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992;326:1445-50.
6. Aubin JT, Agut H, Collandre H, et al. Antigenic and genetic differentiation of the two putative types of human herpes virus 6. J Virol Methods 1993;41:223-34.
7. Schirmer EC, Wyatt LS, Yamanishi K, Rodriquez WJ, Frenkel N. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci USA 1991;88:5922-6.
8. Aubin JT, Collandre H, Candotti D, et al. Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J Clin Microbiol 1991;29:367-72.
9. Chandran B, Tirawatnapong S, Pfeiffer B, Ablashi DV. Antigenic relationships among human herpesvirus-6 isolates. J Med Virol 1992;37:247-54.
10. Ablashi D, Agut H, Berneman Z, et al. Human herpesvirus-6 strain groups: a nomenclature. Arch Virol 1993;129:363-6.
11. Dewhurst S, McIntyre K, Schnabel K, Hall CB. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of US infants. J Clin Microbiol 1993;31:416-8.
12. Cone RW, Huang MLW, Hackman RC, Corey L. Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol 1996;34:877-81.
13. Fillet AM, Raphael M, Visse B, Audouin J, Poirel L, Agut H. Controlled study of human herpesvirus 6 detection in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma. The French Study Group for HIV-associated Tumors. J Med Virol 1995;45:106-12.
14. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-600.
15. Bovenzi P, Mirandola P, Secchiero P, Strumia R, Cassai E, Di Luca D. Human herpesvirus 6 (variant A) in Kaposi's sarcoma [letter]. Lancet 1993;341:1288-9.
16. Wilborn F, Brinkmann V, Schmidt CA, Neipel F, Gelderblom H, Siegert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994;83:3052-8.
17. Carrigan DR, Knox KK. Bone marrow suppression by human herpesvirus-6: comparison of the A and B variants of the virus [letter]. Blood 1995;86:835-6.
18. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991;78:1381-4.
19. Kadakia MP, Rybka WB, Stewart JA, et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996;87:5341-54.
20. Cone RW. Human herpesvirus 6 as a possible cause of pneumonia. Semin Respir Infect 1995;10:254-8.
21. Cone RW, Hackman RC, Huang MLW, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993;329:156-61.
22. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 1992;165:925-9.
23. Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-9.
24. Asano Y, Yoshikawa T, Suga S, et al. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia. N Engl J Med 1991;324:634-5.
25. Cone RW, Huang ML, Ashley R, Corey L. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals (erratum). J Clin Microbiol 1994;32:2633.
26. Cone RW, Hobson AC, Huang MLW. Co-amplified positive control detects inhibition of polymerase chain reactions. J Clin Microbiol 1992;30:3185-9.
27. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
28. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov EBN, Csaki F, eds. Second International Symposium on Information Theory and Control. Budapest: Akademia Kiado, 1973: 267-81.
29. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171:273-80.
30. Frenkel N, Katsafanas GC, Wyatt LS, Yoshikawa T, Asano Y. Bone marrow transplant recipients harbor the B variant of human herpesvirus 6. Bone Marrow Transplant 1994;14:839-43.
31. Drobyski WR, Eberle M, Majewski D, Baxter Lowe LA. Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol 1993;31 1515-20.
32. Rosenfeld CS, Rybka WB, Weinbaum D, et al. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus-6. Exp Hematol 1995;23:626-9.
33. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow transplant recipient. N Engl J Med 1994;330:1356-60.
34. Knox KK, Pietryga D, Harrington DJ, Franciosi R, Carrigan DR. Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant. Clin Infect Dis 1995;20:406-13.
35. Knox KK, Carrigan DR. HHV-6 infection of macrophages in the lungs of AIDS patients: role of HHV-6 as a cofactor in local tissue immunodeficiency [abstract]. Presented at the 18th International Herpesvirus Workshop. Pittsburgh, 1993.